Status:
COMPLETED
Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors
Lead Sponsor:
Tulane University
Conditions:
Hepatitis C
Atherosclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to compare the effect of a cardiovascular education package intervention on treatment-seeking behavioral outcomes of HCV+ patients. This prospective multicenter trial will compare outco...
Detailed Description
Cardiovascular diseases (CVD), including atherosclerosis, are now the leading causes of mortality both in the United States and globally. Unfortunately, the major risk factors that have been targeted ...
Eligibility Criteria
Inclusion
- HCV antibody positive tested at one of six locations in New Orleans: Ozanam Inn, New Orleans Mission, Bethel Colony South, Grace House, St. Anna's Mobile Clinic, and Ruth Fertel
Exclusion
- vulnerable populations including children, prisoners, pregnant women
- non-English speaking patients since effective counseling cannot be provided
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
231 Patients enrolled
Trial Details
Trial ID
NCT03402334
Start Date
March 11 2019
End Date
April 30 2021
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane University HCV Testing Clinics
New Orleans, Louisiana, United States, 70112